H. Arsena and S. M. Munir, “Efficacy and Safety of Adding Antiangiogenic Therapy to EGFR-Tyrosine Kinase Inhibitors versus EGFR-Tyrosine Kinase Inhibitor Monotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomised Controlled Trials”, Bioscmed, vol. 10, no. 7, pp. 2624–2636, Jun. 2026, doi: 10.37275/bsm.v10i7.1638.